Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DoximityDOCS +0.98%82 Revenue per Share is $3.24 as of Mar. 2026. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.33 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Doximity ranks better than 79.45% on this metric.
Doximity's revenue per share for the
three
months ended in Mar. 2026 was $0.75.
Doximity's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $3.24.
During the past 12 months, the average Revenue Per Share Growth Rate of Doximity was 14.30% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 18.20% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 21.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Doximity's Revenue per Share or its related term are showing as below:
DOCS'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 16.4 Med: 25.8 Max: 53.2
Current: 18.2
During the past 8 years, Doximity's highest 3-Year average Revenue Per Share Growth Rate was 53.20% per year. The lowest was 16.40% per year. And the median was 25.80% per year.
DOCS's 3-Year Revenue Growth Rate is ranked better than 79.45% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 6.9
vs DOCS: 18.20
Doximity (NYSE:DOCS) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Doximity Revenue per Share Related Terms
Doximity Revenue per Share Historical Data
* Premium members only.
The historical data trend for Doximity's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCS vs WAY, PRVA, HTFL: Revenue per Share Comparison
For the Health Information Services subindustry, Doximity's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's PS Ratio distribution charts can be found below:
* The bar in red indicates where Doximity's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Doximity's Revenue Per Share for the fiscal year that ended in Mar. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity (DOCS) has a Revenue per Share of $3.24 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Doximity and its competitors. According to the industry distribution chart, Doximity ranks #126 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is Doximity's Revenue per Share too high?
Doximity's current Revenue per Share is $3.24. The Healthcare Providers & Services industry median Revenue per Share is 6.90. Doximity's value of $3.24 is 53% below this industry median. Based on the distribution chart, Doximity ranks #126 out of 613 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Revenue per Share compare to WAY and PRVA?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #126 out of 613 companies for Revenue per Share. This places Doximity in the top 21% of its industry — outperforming the majority of peers. The industry median Revenue per Share is 6.90. Doximity's value of $3.24 is 53% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 6.90, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current Revenue per Share of $3.24 is 53% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current Revenue per Share is $3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.33, compared to a current price of $21.73 — trading 55.9% below its estimated fair value. The current Revenue per Share is $3.24 and 53% below the Healthcare Providers & Services industry median of 6.90. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Doximity (DOCS), the current Revenue per Share is $3.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $21.73 is trading 55.9% below its estimated GF Value™ of $49.33.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
Revenue per Share: $3.24
GF Value™: $49.33 vs. price of $21.73 (55.9% below fair value)
Industry Position: 53% below the Healthcare Providers & Services median (#126 of 613)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
